Showing results (191-200 of 250) with videos related to
Sort By:
Pageof 25
Neuro-Oncology|March 10, 2006
High-dose chemotherapy with stem cell rescue as initial therapy for anaplastic oligodendroglioma: long-term follow-upLauren E Abrey, Barrett H Childs, Nina Paleologos, et al.Journal of Neuro-Oncology|October 9, 2017
Phase I study of sorafenib and tipifarnib for recurrent glioblastoma: NABTC 05-02Phioanh Leia Nghiemphu, Victoria Asuquo Ebiana, Patrick Wen, et al.International Journal of Particle Therapy|November 28, 2019
Clinical Outcomes of Recurrent Intracranial Meningiomas Treated with Proton Beam ReirradiationBrandon S Imber, Brian Neal, Dana L Casey, et al.Journal of Neuro-Oncology|October 6, 2016
Molecular and histologic characteristics of pseudoprogression in diffuse gliomasAndrew L Lin, Michael White, Michelle M Miller-Thomas, et al.Neuro-Oncology|January 20, 2026
Ibrutinib in combination with rituximab, methotrexate, vincristine, and procarbazine (R-MVP/i) for newly diagnosed primary CNS lymphoma (PCNSL)Lauren R Schaff, Elena Pentsova, Rachna Malani, et al.International Journal of Radiation Oncology, Biology, Physics|October 12, 2010
A phase I trial of tipifarnib with radiation therapy, with and without temozolomide, for patients with newly diagnosed glioblastomaPhioanh Leia Nghiemphu, Patrick Y Wen, Kathleen R Lamborn, et al.Neuro-Oncology|February 13, 2010
A phase I trial of erlotinib in patients with nonprogressive glioblastoma multiforme postradiation therapy, and recurrent malignant gliomas and meningiomasJeffrey J Raizer, Lauren E Abrey, Andrew B Lassman, et al.Neuro-Oncology|October 27, 2012
Phase I/II study of sorafenib in combination with temsirolimus for recurrent glioblastoma or gliosarcoma: North American Brain Tumor Consortium study 05-02Eudocia Q Lee, John Kuhn, Kathleen R Lamborn, et al.Acta Neuropathologica|September 12, 2025
Prospective characterization of germline variants in patients with gliomas and glioneuronal tumorsSubhiksha Nandakumar, Miika Mehine, Yelena Kemel, et al.Blood|December 21, 2018
Phase 1b trial of an ibrutinib-based combination therapy in recurrent/refractory CNS lymphomaChristian Grommes, Sarah S Tang, Julia Wolfe, et al.Pageof 25